Metabolic alterations induced by T cells can influence the fate of GBM cells through SLC7A11, while tumor metabolism further contributes to immune evasion by impairing T cell activation via SLC7A11-mediated dysfunction (Figure 5). This evidence concerns the gene SLC7A11 and neoplasm.